Conversion of Immunosuppression From Tacrolimus to Cyclosporine A Improves Insulin Sensitivity and Overall Glucose Tolerance in HCV-Positive Renal Transplant Recipients.

被引:0
|
作者
Schmidt, A. [1 ]
Handisurya, A. [1 ]
Kerscher, C. [1 ]
Tura, A. [2 ]
Werzowa, J. [1 ]
Heinzl, H. [3 ]
Kautzky-Willer, A. [4 ]
Pacini, G. [2 ]
Saemann, M. [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria
[2] CNR, Inst Biomed Engn, Metab Unit, Padua, Italy
[3] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria
[4] Med Univ Vienna, Dept Internal Med 3, Div Endocrinol & Metab, Vienna, Austria
关键词
D O I
10.1097/00007890-201407151-02086
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
D2434
引用
收藏
页码:617 / 617
页数:1
相关论文
共 50 条
  • [41] Conversion from cyclosporine to tacrolimus improves blood pressure and cholesterol levels in heart transplant recipients without affecting the TGF-β system.
    van Riemsdijk, IC
    Baan, CC
    Mol, WM
    Balk, AH
    Vantrimpont, PJ
    Maat, AP
    Weimar, W
    TRANSPLANTATION, 2000, 69 (08) : S293 - S293
  • [42] Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion
    White, M
    Haddad, H
    Leblanc, MH
    Giannetti, N
    Pflugfelder, P
    Davies, R
    Isaac, D
    Burton, J
    Chan, M
    Azevedo, E
    Howlett, J
    Ignaszewski, A
    Busque, S
    Cantarovich, M
    Ferguson, R
    Genest, J
    Ross, H
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (07): : 798 - 809
  • [43] No Improvement in Insulin Sensitivity in Renal Transplant Recipients Converted from Standard to Once-Daily Prolonged Release Tacrolimus.
    Midtvedt, K.
    Jenssen, T.
    Hartmann, A.
    Vethe, N. T.
    Bergan, S.
    Haynes, K.
    Asberg, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 372 - 372
  • [44] Late conversion from tacrolimus to a belatacept-based immunosuppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism
    Schulte, Kevin
    Vollmer, Clara
    Klasen, Vera
    Braesen, Jan Hinrich
    Puechel, Jodok
    Borzikowsky, Christoph
    Kunzendorf, Ulrich
    Feldkamp, Thorsten
    JOURNAL OF NEPHROLOGY, 2017, 30 (04) : 607 - 615
  • [45] Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients
    Blume, C
    Hollenbeck, M
    Ivens, K
    Heering, P
    Hetzel, GR
    Grabensee, B
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3161 - 3163
  • [46] Beta cell function and insulin resistance after the conversion from tacrolimus twice daily to extended-release tacrolimus once daily in stable renal transplant recipients
    Ruangkanchanasetr, Prajej
    Sanohdontree, Natthi
    Supaporn, Thanom
    Leawseng, Sirilak
    Satirapoj, Bancha
    TRANSPLANTATION, 2016, 100 (07) : S413 - S413
  • [47] SIGNIFICANTLY BETTER FREEDOM FROM ACUTE REJECTION WITH TACROLIMUS VERSUS CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS AT 7-YEAR FOLLOW-UP
    Kraemer, B.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 8 - 8
  • [48] Renal Function and Safety Post-Conversion from Twice-Daily to Once-Daily Tacrolimus: A Multicenter, Crossover Study in Liver Transplant Recipients.
    Boillot, O.
    Paczek, L.
    Wolf, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 535 - 536
  • [49] CONVERSION FROM TACROLIMUS TO CYCLOSPORINE A IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION: INTERIM ANALYSIS OF A PROSPECTIVE AND RANDOMIZED STUDY
    Wissing, Karl M.
    Kuypers, Dirk
    Abramowicz, Daniel
    Weekers, Laurent
    Budde, Klemens M. D.
    Rath, Thomas
    Witzke, Oliver
    TRANSPLANT INTERNATIONAL, 2013, 26 : 37 - 37
  • [50] Short-Term Renal Function in Long-Term Kidney Transplant Recipients after Conversion from Cyclosporine A to Tacrolimus. A Randomized Controlled Trial
    Plischke, M.
    Riegersperger, M.
    Steiner, S.
    Seidinger, D.
    Winkelmayer, W. C.
    Sunder-Plassmann, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 204 - 204